tiprankstipranks
Trending News
More News >
Nuvalent (NUVL)
NASDAQ:NUVL
US Market
Advertisement

Nuvalent (NUVL) Similar Stocks

Compare
145 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Nuvalent
$109.06
$7.93B
12.71%
16 Buy
0 Hold
0 Sell
Strong Buy
Cytokinetics
$68.15
$8.33B
31.41%
14 Buy
2 Hold
0 Sell
Strong Buy
TG Therapeutics
$33.41
$5.30B
12.03
-4.54%
4 Buy
0 Hold
1 Sell
Moderate Buy
Axsome Therapeutics
$150.98
$7.61B
53.72%
15 Buy
0 Hold
0 Sell
Strong Buy
Merus
$96.09
$7.29B
113.68%
2 Buy
14 Hold
0 Sell
Hold
Avidity Biosciences
$71.56
$10.78B
66.30%
5 Buy
10 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
NUVL
Nuvalent
109.06
12.38
12.81%
CYTK
Cytokinetics
68.15
16.29
31.41%
TGTX
TG Therapeutics
33.41
-1.39
-3.99%
AXSM
Axsome Therapeutics
150.98
52.76
53.72%
MRUS
Merus
96.09
51.25
114.30%
RNA
Avidity Biosciences
71.56
28.53
66.30%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis